Skip to content
Review

The future of pediatric gene therapy: CRISPR-Cas9, AI, and personalized medicine.

Jul 2026 · Pediatric Research · 0 citations · 348 references
Medicine

TL;DR

Pediatric gene therapy holds transformative potential to provide curative solutions for children, and the establishment of standardized regulatory frameworks, accompanied by robust and transparent AI integration, will be essential to ensure safe, equitable, and scalable translation.

View source

Similar papers

Review Open access Jul 2026

CRISPR/Cas9 in cancer therapy: clinical translation, mechanistic strategies, and therapeutic directions

Overall, CRISPR/Cas9 represents a promising yet evolving platform in oncology, with its future clinical success dependent on achieving a balance between precision, safety, scalability, and long-term therapeutic durability.

C. Ng, Sakina Mustafa, X. Y. Yap et al. · 0 citations
Review Open access Aug 2026

CRISPR-Cas9 gene editing approaches in colorectal cancer: Current progress and future prospects.

Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide, characterized by genetic heterogeneity and the accumulation of mutations in key oncogenes and tumor suppressor genes. CRISPR-Cas9 technology has greatly advanced genetic research by enabling precise genome editing. This review focuses on the...

Mohadeseh Hassannia, P. Amirifar · 0 citations
#gene editing Review Sep 2026

CRISPR–cas systems in pharmacology: functional pharmacogenomics, drug screening, resistance, and therapeutic translation

Overall, CRISPR-Cas9 represents a vital platform for future pharmacological innovation, but its broad clinical use may require further validation of safety, efficacy, durability, and accessibility.

Muhammad Saeed Akhtar, Adnan Amin · 0 citations
Review Open access Jul 2026

CRISPR-Based Genome Editing in Contemporary Clinical Medicine: Therapeutic Translation, Global Challenges and the Future of Precision Medicine

CRISPR has progressed from an experimental genome-engineering technology to a clinically relevant therapeutic platform, although its future impact will depend on the ability to combine molecular precision and durable therapeutic benefit with rigorous safety assessment, responsible governance, and equitable access acros...

Gabriel Alejandro Ortega Moreno, Gerardo Amaya Villagran, A. González et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.